跳至主要内容
临床试验/NCT01722916
NCT01722916已完成1 期

Pilot Study of Appropriate Dosing for Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase: A Randomized Control Clinical Trial

Northwestern University2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2012年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
5
试验地点
2
主要终点
Dose of hyaluronidase injected until the filler is no longer detectable

研究概览

简要总结

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 and over
  • The subjects are in good health
  • The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator

排除标准

  • Under 18 years of age
  • Pregnancy or Lactation
  • Subjects who are unable to understand the protocol or to give informed consent
  • Subjects with mental illness
  • Recent Accutane use in the past 6 months
  • Subjects prone to hypertrophic and keloidal scarring
  • Subjects with tattoos and/or scars on upper medial arms (the treatment area)
  • Subjects with known hypersensitivity to hyaluronic acid

研究组 & 干预措施

Dose of Hyaluronidase

Experimental

干预措施: Hyaluronidase (Drug)

结局指标

主要结局

Dose of hyaluronidase injected until the filler is no longer detectable

时间窗: 2 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Murad Alam

Professor in Dermatology, Otolaryngology- Head and Neck Surgery and Surgery-Organ Transplantation

Northwestern University

研究点 (2)

Loading locations...

相似试验